ABC | Volume 110, Nº3, March 2018

Original Article Almeida Junior et al BNP, echo and clinical evaluation in heart failure Arq Bras Cardiol. 2018; 110(3):270-277 29. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al; BreathingNotProperlyMultinationalStudyInvestigators.Rapidmeasurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-7. doi: 10.1056/NEJMoa020233. 30. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol. 2007;49(19):1943-50. doi: https://doi. org/10.1016/j.jacc.2007.02.037. 31. Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, et al; Rapid Emergency Department Heart Failure Outpatient Trial investigators. Primary results of the Rapid Emergency Department Heart Failure OutpatientTrial (REDHOT).AmulticenterstudyofB-typenatriureticpeptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J AmColl Cardiol. 2004;44(6):1328-33. doi: https://doi.org/10.1016/j.jacc.2004.06.015. 32. Drazner MH, Hellkamp AS, Leier CV, Shah MR, Miller LW, Russell SD, et al. Value of clinical assessment of hemodynamics in advanced heart failure: the ESCAPE Trial. Circ Heart Fail. 2008;1(3):170-7. doi: 10.1161/ CIRCHEARTFAILURE.108.769778. 33. ForfiaPR,WatkinsSP,RameE,StewartKJ,ShapiroEP.RelationshipbetweenB-type natriureticpeptidesandpulmonarycapillarywedgepressureintheintensivecare unit.JAmCollCardiol.2005;45(10):1667-71.doi:10.1016/j.jacc.2005.01.046. 34. Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail. 2001;7(1):21-9. doi: 10.1054/jcaf.2001.23355. 35. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, et al; TIME-CHF Investigators. BNP-guided VS symptom guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly PatientsWithCongestiveHeart Failure (TIME-CHF) randomized trial. JAMA. 2009;301(4):383-92. doi: 10.1001/jama.2009.2. 36. Januzzi Jr JL, Rehman SU, Mohammed AA, Bhardwaj A, Barajas L, Barajas J, et al. Use of amino-terminal Pro–B-Type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol. 2011;58(18):1881-9. doi: 10.1016/j. jacc.2011.03.072. 37. Collins SP, Lindsell CJ, PeacockWF, Hedger VD, Askew J, Eckert DC, et al. The combined utility of an S3 heart sound and B-type natriuretic peptide levels in emergency department patients with dyspnea. J Card Fail. 2006;12(4):286- 92. doi: 10.1016/j.cardfail.2006.01.012. 38. Temporelli PL, Scapellato F, Eleuteri E, Imparato A, Giannuzzi P. Doppler echocardiography in advanced systolic heart failure, a noninvasive alternative to Swan-Ganz catheter. Circ Heart Fail. 2010;3(3):387-94. doi: 10.1161/CIRCHEARTFAILURE.108.809590. 39. Nagueh SF, Bhatt R, Vivo RP, Krim SR, Sarvari SI, Russell K, et al. Echocardiographic evaluation of hemodynamics in patients with decompensated systolic heart failure. Circ Cardiovasc Imaging. 2011;4(3):220-7. doi: 10.1161/CIRCIMAGING.111.963496. 40. Stein JH, Neumann A, Preston LM, Constanzo MR, Parrillo JE, Johnson MR, et al. Echocardiographic for hemodynamic assessment of patients with advanced heart failure and potential heart transplant recipients. J Am Coll Cardiol. 1997;30(7):1765-72. doi: https://doi.org/10.1016/S0735- 1097(97)00384-7. This is an open-access article distributed under the terms of the Creative Commons Attribution License 277